Serum Institute CEO Adar Poonawalla said on December 7 that the company had applied to the DCGI for emergency use the authorisation of the COVID-19 vaccine candidate Covishield.from Moneycontrol Latest News https://ift.tt/3gnBcig
COVID-19 vaccine may cost Rs 250 per dose, says Serum Institute: Report
Serum Institute CEO Adar Poonawalla said on December 7 that the company had applied to the DCGI for emergency use the authorisation of the COVID-19 vaccine candidate Covishield.from Moneycontrol Latest News https://ift.tt/3gnBcig
Post a Comment
Post a Comment
please do not enter spam link in the comment box